Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OPERATING ACTIVITIES:
Net income	$ 134,650	$ (52,705)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, depletion, and amortization	3,891	11,270
(Gain) loss on derivatives, net (Note 12)	(13,595)	64,076
Gain (loss) on derivatives settled (Note 12)	2,601	(21,239)
Deferred	(74,836)	0
Loss on change in fair value of warrants (Note 12)	0	36,612
Loss on deconsolidation of Superior	0	13,141
Gain on disposition of assets (Note 4)	(3,753)	(2,175)
Stock-based compensation plans (Note 6)	1,408	1,038
Change in credit loss reserve	62	(29)
ARO liability accretion	467	493
Contract assets and liabilities, net (Note 3)	816	199
Noncash reorganization items	(70)	(77)
Other, net	(226)	(401)
Changes in operating assets and liabilities increasing (decreasing) cash:
Accounts receivable	8,569	(12,532)
Prepaid expenses and other	1,061	1,466
Accounts payable	(1,058)	4,107
Accrued liabilities	(2,587)	2,566
Increase (Decrease) in Operating Capital	5,985	(4,393)
Net cash provided by operating activities	57,400	45,810
INVESTING ACTIVITIES:
Capital expenditures	(8,886)	(8,784)
Deconsolidation of Superior cash and cash equivalents (Note 15)	0	(10,119)
Proceeds from Sale of Productive Assets	4,797	6,691
Net Cash Provided by (Used in) Investing Activities, Total	(4,089)	(12,212)
FINANCING ACTIVITIES:
Dividend and dividend equivalent payments	(96,458)	0
Payments for employee taxes on net settlement of equity awards	(108)	0
Proceeds from exercise of warrants	192	0
Distributions to non-controlling interests (Note 15)	0	(9,479)
Net cash used in financing activities	(96,374)	(9,479)
Net increase (decrease) in cash and cash equivalents	(43,063)	24,119
Cash, restricted cash, and cash equivalents, beginning of year	213,975	64,140
Cash, restricted cash, and cash equivalents, end of year	$ 170,912	$ 88,259